Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

MIMEDX GRP INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2025202420232022202120202019201820162015
Period End Date12/31/202512/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201612/31/2015
Net Sales418.63348.88321.48267.84258.62248.23299.26359.11245.02187.30
Grant revenue--------------------
Total Revenues418.63348.88--267.84258.62248.23299.26359.11245.02187.30
Cost of sales73.0160.0754.6348.3243.2839.3343.0836.3932.4120.20
Gross Margin345.62288.81266.84219.53215.33208.90256.17322.73212.61167.09
Amortization of intangible assets0.440.770.760.700.821.071.041.032.130.93
Research and development expenses15.1012.3412.6722.8317.3411.7211.1415.7712.048.41
Acquired in-process research and development--------------------
Selling, general and administrative expenses266.19225.09211.12208.79198.36181.02198.21258.53180.00133.38
Impairment of intangible assets--(0.45)----(0.05)(1.03)(0.45)------
Gain on sale of assets--------------------
Fair value adjustment of earn-out liability--------------------
Investigation, restatement and related--8.70(5.18)(12.18)(3.79)(59.47)(66.50)(51.32)----
Operating Income (Loss)63.8958.8737.12(24.97)(5.04)(45.40)(21.16)(3.92)18.4524.36
Interest expense, net--1.016.465.024.98------0.34--
Change in fair value of investment, related party--------------------
Interest (expense) income, net2.93--------(7.94)(4.71)----(0.09)
Other income (expense), net(0.56)(0.57)(0.03)0.00(0.02)0.000.280.53----
Amortization of debt discount--------------------
Financing expense associated with warrants issued in connection with convertible promissory note--------------------
Financing expense associated with issuance of common stock for registration rights waivers--------------------
Loss on extinguishment of debt----------(8.20)--------
Income (loss) before income tax provision66.2657.2930.63(29.99)(10.04)(61.54)(25.59)(3.40)18.1124.28
Income tax (benefit) provision17.6815.30(36.81)0.210.25(12.26)(0.01)26.586.13(5.17)
Net income (loss) from continuing operations48.5842.0067.44--------------
Income (Loss) from discontinued operations, net of tax--0.42(9.21)--------------
Net Loss48.5842.4258.23(30.20)(10.29)(49.28)(25.58)----29.45
Accretion of redeemable common stock and common stock with registration rights to fair value----6.756.586.14----------
Preferred share repurchase in excess of book value----4.89--------------
Net Income (Loss) Available to Common Shareholders48.5842.4246.59(36.78)(16.42)(49.28)(25.58)(29.98)11.9729.45
Basic net income (loss) per common share:Continuing operations0.330.29----------------
Basic net income (loss) per common share:Discontinued operations--0.00----------------
Net Earnings Per Share (Basic)0.330.290.40(0.33)(0.15)(0.77)(0.24)(0.28)0.110.28
Diluted net income (loss) per common share:Continuing operations0.320.28----------------
Diluted net income (loss) per common share:Discontinued operations--0.00----------------
Net Earnings Per Share (Diluted)0.320.280.37(0.33)(0.15)(0.77)(0.24)(0.28)0.110.26
Weighted Average Shares Outstanding (Basic)147.79146.98116.50112.91110.35108.26106.95105.60105.93105.93
Weighted Average Shares Outstanding (Diluted)149.72149.05145.96112.91110.35108.26106.95105.60112.44113.63